STEFANIE MORRIS: Open Payments
NPI 1437646510 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,984 in 161 payments from 19 companies in 2025. Trend: 2023 $2,155 · 2024 $2,088 · 2025 $2,984
Food & beverage: $2,944Education: $40
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $656 |
| Madrigal Pharmaceuticals | 13 | $466 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $301 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $263 |
| Novo Nordisk Inc | 6 | $176 |
| Aimmune Therapeutics, Inc. | 11 | $175 |
| Ardelyx, Inc. | 11 | $157 |
| Regeneron Healthcare Solutions, Inc. | 4 | $129 |
| Janssen Biotech, Inc. | 6 | $117 |
| GENZYME CORPORATION | 5 | $102 |
Products named: REZDIFFRA, RINVOQ, ENTYVIO, XIFAXAN, DUPIXENT, Wegovy, ZENPEP, IBSRELA.
Industry payments across TN — which companies pay providers there.
